Email this page

Mandatory fields are marked with an asterisk [*].

Fill in your email details
1. * Your name:
2. * Your email address:
3. * Recipient name:
4. * Recipient email address:
Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.
Change the message if you want to
1. To: <recipient name> <address>
2. From: <sender name> <address>
3. Subject: <sender name> is sending you a link
4. Hi,
  I saw this on the Smith & Nephew site and thought you might be interested.
5. <sender name>
Visitor verfication
1. *Type the code shown

Enabling technologies

Key products

View our key products

Patient stories

See how our products improve patients' lives

We have identified a number of Group Significant Technologies. With possible applications across our Group Business Units, they appear to offer us the greatest potential for sustained competitive advantage. In a number of cases they have already, in their early phases of exploitation, been translated into end products.

Three of these technologies are the focus of our Enabling Technologies research programme, which is based at the Smith & Nephew Research Centre in York, England and at selected international academic centres.

These focus technologies are:

Novel bioresorbable polymers
Tissue or cell engineering
Non-invasive stimulation

In York, the Enabling Technologies group is located alongside research groups from each of the Group Business Units – ensuring close collaboration and the efficient transfer of these platform technologies into product development pipelines.